Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 23751-23800 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06471673
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
PHASE1/PHASE2
Recruiting
18 participants
Started: May 29, 2024 · Completed: Oct 30, 2025
6 conditions
1 sponsor
1 location
NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
PHASE1/PHASE2
Recruiting
60 participants
Started: May 29, 2024 · Completed: Dec 28, 2026
4 conditions
1 sponsor
1 location
NCT06412666
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
PHASE2/PHASE3
Recruiting
40 participants
Started: May 29, 2024 · Completed: Jan 31, 2030
2 conditions
1 sponsor
38 locations
NCT06318897
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
PHASE2
Recruiting
28 participants
Started: May 29, 2024 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT06266390
Individualized (fMRI-guided) TMS Treatment for Depression
NA
Recruiting
50 participants
Started: May 29, 2024 · Completed: Apr 30, 2026
3 conditions
3 sponsors
1 location
NCT06538961
Immune Registry for BK in Kidney Transplant Recipients
N/A
Recruiting
60 participants
Started: May 29, 2024 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT06361641
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NA
Recruiting
70 participants
Started: May 29, 2024 · Completed: Oct 19, 2027
4 conditions
1 sponsor
3 locations
NCT05266846
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
PHASE2
Recruiting
78 participants
Started: May 29, 2024 · Completed: Feb 16, 2027
3 conditions
1 sponsor
1 location
NCT06366789
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia
PHASE1
Recruiting
60 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06355791
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
NA
Recruiting
150 participants
Started: May 29, 2024 · Completed: Dec 31, 2030
3 conditions
1 sponsor
6 locations
NCT06805045
Image-Guided Surgery In The Treatment Of Rectal Cancer (AR_CRC)
NA
Recruiting
50 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06263491
Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
PHASE2
Recruiting
50 participants
Started: May 29, 2024 · Completed: Mar 1, 2027
1 condition
1 sponsor
1 location
NCT06360354
A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
PHASE1
Recruiting
350 participants
Started: May 29, 2024 · Completed: Feb 25, 2029
1 condition
1 sponsor
77 locations
NCT06867315
The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia
NA
Recruiting
10 participants
Started: May 29, 2024 · Completed: May 29, 2026
1 condition
5 sponsors
1 location
NCT06167655
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NA
Recruiting
250 participants
Started: May 29, 2024 · Completed: Aug 30, 2026
1 condition
1 sponsor
20 locations
NCT06296394
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
N/A
Recruiting
146 participants
Started: May 29, 2024 · Completed: Feb 1, 2031
2 conditions
3 sponsors
18 locations
NCT06427239
Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
35 participants
Started: May 29, 2024 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06474234
Modulation of Gut Microbiota by Probiotic in Children
PHASE2
Recruiting
120 participants
Started: May 29, 2024 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT06283797
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
NA
Recruiting
112 participants
Started: May 29, 2024 · Completed: Jun 29, 2027
1 condition
5 sponsors
4 locations
NCT06450483
Compare the Effects of Different AVNS Parameters on Neck Pain, HRV, Balance in Collegiate Atheletes
NA
Recruiting
70 participants
Started: May 29, 2024 · Completed: Jul 8, 2024
3 conditions
1 sponsor
1 location
NCT06445088
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
N/A
Recruiting
908 participants
Started: May 29, 2024 · Completed: Dec 31, 2026
1 condition
5 sponsors
5 locations
NCT06419634
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
PHASE1
Recruiting
105 participants
Started: May 29, 2024 · Completed: Sep 16, 2030
2 conditions
1 sponsor
15 locations
NCT06256354
Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival
NA
Recruiting
3,992 participants
Started: May 29, 2024 · Completed: Jun 30, 2032
4 conditions
2 sponsors
34 locations
NCT06616363
Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?
N/A
Recruiting
120 participants
Started: May 29, 2024 · Completed: Jul 31, 2028
1 condition
2 sponsors
1 location
NCT06281665
Treatment With Aspirin After Preeclampsia: TAP Trial
PHASE4
Recruiting
60 participants
Started: May 29, 2024 · Completed: Jun 1, 2027
11 conditions
2 sponsors
1 location
NCT06445842
Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women
NA
Recruiting
46 participants
Started: May 29, 2024 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06382350
Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
N/A
Recruiting
120 participants
Started: May 29, 2024 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT06480656
Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease
NA
Recruiting
22 participants
Started: May 29, 2024 · Completed: Jul 1, 2026
1 condition
1 sponsor
2 locations
NCT06211257
Superiority Trial Evaluating Digitalized Information Media for Patients with Advanced Sarcomas Receiving Second Line Treatment.
NA
Recruiting
377 participants
Started: May 29, 2024 · Completed: Mar 31, 2028
2 conditions
2 sponsors
10 locations
NCT06504368
Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
PHASE1
Recruiting
32 participants
Started: May 29, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06259435
Modulating Energy Density in Time-Restricted Eating
NA
Recruiting
40 participants
Started: May 29, 2024 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT06470594
Superficial and Deep Endometriosis: Role of Systemic Inflammation as a Marker of Clinical, Surgical, and Reproductive Outcomes
N/A
Recruiting
138 participants
Started: May 29, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06131775
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer
NA
Recruiting
300 participants
Started: May 29, 2024 · Completed: May 1, 2028
1 condition
1 sponsor
4 locations
NCT06469372
Cardiac Amyloidosis Discovery Trial
NA
Recruiting
100 participants
Started: May 28, 2024 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT06564402
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NA
Recruiting
40 participants
Started: May 28, 2024 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT06548867
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
N/A
Recruiting
80 participants
Started: May 28, 2024 · Completed: Jun 30, 2025
1 condition
3 sponsors
1 location
NCT06379698
Rein 3D PRINT PERSONALIZE
NA
Recruiting
39 participants
Started: May 28, 2024 · Completed: Jun 15, 2027
1 condition
1 sponsor
1 location
NCT06347471
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
PHASE4
Recruiting
120 participants
Started: May 28, 2024 · Completed: Apr 30, 2026
1 condition
3 sponsors
2 locations
NCT06932042
PLADO for Conservative Management of CKD
NA
Recruiting
48 participants
Started: May 28, 2024 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT07004569
Angiolite Registry Study
N/A
Recruiting
55 participants
Started: May 28, 2024 · Completed: Jul 28, 2025
1 condition
1 sponsor
1 location
NCT06800911
Metacognitive Beliefs in Obese Patients
N/A
Recruiting
90 participants
Started: May 28, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06332430
Intratumoral CAN2109 in Subjects With Solid Tumors
PHASE1
Recruiting
27 participants
Started: May 28, 2024 · Completed: May 30, 2026
2 conditions
1 sponsor
1 location
NCT06454734
Shock Wave Therapy for Lower Limb Lymphedema
NA
Recruiting
30 participants
Started: May 28, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06022458
Prenatal Sonographic Prediction of Placental Histology and Function
N/A
Recruiting
320 participants
Started: May 28, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06282965
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
PHASE1/PHASE2
Recruiting
90 participants
Started: May 28, 2024 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT06449430
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
NA
Recruiting
270 participants
Started: May 28, 2024 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06271239
Effect of Multicomponent Exercises VIVIFRAIL® in Older Adults
NA
Recruiting
50 participants
Started: May 28, 2024 · Completed: May 30, 2025
3 conditions
2 sponsors
4 locations
NCT06273436
Healing, Equity, Advocacy and Respect for Mamas
NA
Recruiting
2,894 participants
Started: May 28, 2024 · Completed: Nov 30, 2028
1 condition
2 sponsors
1 location
NCT06388954
Plasticity Biomarkers,Interleukin-6 and Motor Performance in Response to Vagus Nerve Stimulation After Stroke
NA
Recruiting
80 participants
Started: May 28, 2024 · Completed: May 18, 2025
2 conditions
1 sponsor
1 location
NCT06100263
Breast Cancer Resiliency Through Exercise Program (B-REP)
NA
Recruiting
200 participants
Started: May 28, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
473
474
475
476
477
478
479
More pages
1333
Next